Sort
25,944 grants matching “neurodegeneration”
Membrane lipid peroxidation in pathogenesis of Alzheimerâs disease
$385,000Qitao Ran · University Of Texas Hlth Science Center · R01 · FY2020 · AG
Role of VAMP1 in synaptic transmission and Alzheimer's dementia
$385,000Ferenc Deak · Augusta University · R01 · FY2021 · AG
Deciphering the Mechanisms and Cellular Roles of Monomer-Driven Actin Dynamics
$385,000Eric A Vitriol · Augusta University · R35 · FY2022 · GM
Mechanism and effects of communication between actin and gene regulatory complexes
$385,000Ryan David Mohan · Wayne State University · R01 · FY2025 · NS
Regulation of epigenome stability by SIRT6 during aging. Supplement: Does centenarian variant of SIRT6 or bowhead whale SIRT6 confer protection from Alzheimer's disease?
$385,000Andrei Seluanov · University Of Rochester · R37 · FY2020 · AG
Mechanisms of Neurodegeneration in Lewy Body Disorders
$385,000Vivek Unni · Oregon Health & Science University · R01 · FY2019 · NS
Oxidative stress and RNA methylation
$385,000Ricardo C Aguiar · University Of Texas Hlth Science Center · R01 · FY2020 · ES
Biology &Pharmaclogy of the GDNF Family of Ligands
$385,000Washington University · R01 · FY2001 · AG
Role of glyoxalase-1 in Alzheimer's disease pathogenesis and therapy
$385,000Swati S More · University Of Minnesota · R01 · FY2022 · AG
Comparative genomics of longevity. Supplement: Establishing degu as a new animal model for Alzheimer's disease.
$385,000Vera Gorbunova · University Of Rochester · P01 · FY2020 · AG
Mechanisms of longevity in the naked mole rat: high molecular weight hyaluronan and stable epigenome. Supplement: Hyaluronan from naked mole rats as potential Alzheimer's disease therapy.
$385,000Vera Gorbunova · University Of Rochester · P01 · FY2020 · AG
Deciphering the Mechanisms and Cellular Roles of Monomer-Driven Actin Dynamics
$385,000Eric A Vitriol · Augusta University · R35 · FY2021 · GM
The role of SIRT6 posttranslational modifications in aging and genome stability. Supplement: Testing SIRT6 activators as potential Alzheimer's disease therapy.
$385,000Vera Gorbunova · University Of Rochester · R01 · FY2020 · AG
Mechanisms of Neurodegeneration in Lewy Body Disorders
$385,000Vivek Unni · Oregon Health & Science University · R01 · FY2017 · NS
Mechanisms of Neurodegeneration in Lewy Body Disorders
$385,000Vivek Unni · Oregon Health & Science University · R01 · FY2021 · NS
Biology &Pharmaclogy of the GDNF Family of Ligands
$385,000Washington University · R01 · FY2005 · AG
Mechanisms of Neurodegeneration in Lewy Body Disorders
$385,000Vivek Unni · Oregon Health & Science University · R01 · FY2020 · NS
Mechanisms and Therapeutic Targeting of Chronic Neuroinflammation in Traumatic Brain Injury
$385,000Darrell W Brann · Augusta University · R01 · FY2022 · NS
Role of glyoxalase-1 in Alzheimer's disease pathogenesis and therapy
$385,000Swati S More · University Of Minnesota · R01 · FY2019 · AG
Role of glyoxalase-1 in Alzheimer's disease pathogenesis and therapy
$385,000Swati S More · University Of Minnesota · R01 · FY2020 · AG
Biology &Pharmaclogy of the GDNF Family of Ligands
$385,000Washington University · R01 · FY2004 · AG
Biology &Pharmaclogy of the GDNF Family of Ligands
$385,000Washington University · R01 · FY2003 · AG
Regulation of genome stability by SIRT6
$385,000Andrei Seluanov · University Of Rochester · R01 · FY2018 · AG
Biology &Pharmaclogy of the GDNF Family of Ligands
$385,000Washington University · R01 · FY2002 · AG
Local protein synthesis in tau pathology neurodegeneration
$385,000Joongkyu Park · Wayne State University · R01 · FY2024 · AG